Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMRN | Amarin Corp. Plc | 0.28% | 21.55 | 1.7% | $182.31m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 1.35% | 27.75 | 14.1% | $163.28m | |
| BHC | Bausch Health Cos., Inc. | 1.35% | 27.75 | 0.0% | $118.60m | |
| GWPH | GW Pharmaceuticals Plc | -4.52% | 106.01 | 6.2% | $79.85m | |
| MDCO | The Medicines Co. | -3.64% | 50.89 | 20.2% | $77.88m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.38% | 133.82 | 2.3% | $62.86m | |
| SAGE | SAGE Therapeutics, Inc. | -2.26% | 140.79 | 8.6% | $50.65m | |
| PRGO | Perrigo Co. Plc | -0.77% | 48.02 | 6.8% | $47.61m | |
| ENDP | Endo International Plc | -3.03% | 4.16 | 8.8% | $44.77m | |
| UTHR | United Therapeutics Corp. | 1.18% | 89.53 | 14.3% | $39.39m | |
| HZNP | Horizon Therapeutics Plc | -1.62% | 29.81 | 6.6% | $38.74m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -1.04% | 83.05 | 16.9% | $38.71m | |
| ICLR | ICON plc | 1.41% | 152.42 | 4.2% | $37.87m | |
| CTLT | Catalent, Inc. | -0.89% | 49.11 | 2.4% | $31.43m | |
| ARGX | argenx SE | 0.58% | 137.38 | 0.0% | $26.76m |
Company Profile
Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY.